Variant report
Variant | esv3368231 |
---|---|
Chromosome Location | chr13:54269000-54286267 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs150828838 | chr13:54269003-54269004 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs139829204 | chr13:54269010-54269011 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs9536516 | chr13:54269059-54269060 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs548004391 | chr13:54269065-54269066 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs566718605 | chr13:54269076-54269077 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs189931239 | chr13:54269084-54269085 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs549138890 | chr13:54269091-54269092 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs568339308 | chr13:54269121-54269122 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs180723330 | chr13:54269166-54269167 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs144100429 | chr13:54269177-54269178 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs536732593 | chr13:54269189-54269190 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs186591045 | chr13:54269199-54269200 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs539510523 | chr13:54269202-54269203 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs553046840 | chr13:54269205-54269206 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs147325617 | chr13:54269238-54269239 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs2806725 | chr13:54269256-54269257 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs114718316 | chr13:54269265-54269266 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs575857381 | chr13:54269311-54269312 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs544510178 | chr13:54269314-54269315 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs140964449 | chr13:54269328-54269329 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs577832213 | chr13:54269471-54269472 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs149821657 | chr13:54269472-54269473 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs560614490 | chr13:54269473-54269474 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529413228 | chr13:54269527-54269528 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs549348122 | chr13:54269559-54269560 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs562747918 | chr13:54269616-54269617 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530777943 | chr13:54269652-54269653 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs111279702 | chr13:54269663-54269664 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs576624746 | chr13:54269669-54269670 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs539388993 | chr13:54269684-54269685 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561309959 | chr13:54269815-54269816 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs552807867 | chr13:54269897-54269898 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs570623948 | chr13:54269918-54269919 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs1889996 | chr13:54269950-54269951 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs190980649 | chr13:54269971-54269972 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs376031258 | chr13:54269986-54269987 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs144963478 | chr13:54269995-54269996 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs183837956 | chr13:54270003-54270004 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs148643135 | chr13:54270066-54270067 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs574919178 | chr13:54270096-54270097 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs538115528 | chr13:54270129-54270130 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs547313107 | chr13:54270158-54270159 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs199765571 | chr13:54270263-54270264 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs558013723 | chr13:54270280-54270281 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs577947392 | chr13:54270445-54270446 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs540819018 | chr13:54270462-54270463 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs9596841 | chr13:54270467-54270468 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs554779180 | chr13:54270499-54270500 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs111757015 | chr13:54270519-54270520 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs111278291 | chr13:54270527-54270528 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 19242612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Multiple myeloma | 19135901 | CNVD |
Autism | 18414403 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Prostate cancer | 16461572 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21858162 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Gastric cancer | 17908304 | CNVD |
Breast cancer | 18852474 | CNVD |
Myelofibrosis | 22110671 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Schizophrenia | 20967226 | CNVD |
Schizophrenia | 23813976 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:54265800-54269200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
2 | chr13:54266000-54269000 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr13:54266000-54269000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
4 | chr13:54266000-54269200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
5 | chr13:54266000-54269200 | Weak transcription | H1 Cell Line | embryonic stem cell |
6 | chr13:54266000-54287200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr13:54268400-54269400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
8 | chr13:54268400-54269800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
9 | chr13:54268800-54269400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
10 | chr13:54268800-54269600 | Enhancers | H9 Cell Line | embryonic stem cell |
11 | chr13:54268800-54269600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
12 | chr13:54268800-54270000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr13:54269000-54269400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
14 | chr13:54269000-54269600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
15 | chr13:54269000-54269600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
16 | chr13:54269000-54269600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
17 | chr13:54269000-54269600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
18 | chr13:54269200-54269600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
19 | chr13:54269200-54269600 | Enhancers | H1 Cell Line | embryonic stem cell |
20 | chr13:54269200-54269600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
21 | chr13:54269400-54270600 | Enhancers | Fetal Lung | lung |